Abbvie Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
143.41
1.02
(0.716%)
Volume:
4,903,432
52 week range:
128.24 - 162.75
Market Cap:
253.196B
Company Description:
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.